Jin Medical International (ZJYL) Competitors $0.70 -0.01 (-1.28%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.72 +0.02 (+2.49%) As of 03/28/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ZJYL vs. NPCE, NYXH, CLPT, SMLR, NNOX, CVRX, SNWV, TCMD, ZIMV, and SMTIShould you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include NeuroPace (NPCE), Nyxoah (NYXH), ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), CVRx (CVRX), SANUWAVE Health (SNWV), Tactile Systems Technology (TCMD), ZimVie (ZIMV), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry. Jin Medical International vs. NeuroPace Nyxoah ClearPoint Neuro Semler Scientific Nano-X Imaging CVRx SANUWAVE Health Tactile Systems Technology ZimVie Sanara MedTech NeuroPace (NASDAQ:NPCE) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking. Which has more risk & volatility, NPCE or ZJYL? NeuroPace has a beta of 2.06, meaning that its stock price is 106% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 13.75, meaning that its stock price is 1,275% more volatile than the S&P 500. Does the media favor NPCE or ZJYL? In the previous week, NeuroPace had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.63 beat NeuroPace's score of 0.30 indicating that Jin Medical International is being referred to more favorably in the news media. Company Overall Sentiment NeuroPace Neutral Jin Medical International Positive Do analysts rate NPCE or ZJYL? NeuroPace presently has a consensus target price of $15.20, suggesting a potential upside of 28.27%. Given NeuroPace's stronger consensus rating and higher possible upside, equities analysts clearly believe NeuroPace is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer NPCE or ZJYL? NeuroPace received 31 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformNeuroPaceOutperform Votes3160.78% Underperform Votes2039.22% Jin Medical InternationalN/AN/A Do institutionals & insiders have more ownership in NPCE or ZJYL? 78.8% of NeuroPace shares are held by institutional investors. 22.2% of NeuroPace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, NPCE or ZJYL? Jin Medical International has lower revenue, but higher earnings than NeuroPace. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$79.91M4.83-$32.96M-$0.95-12.47Jin Medical International$23.50M4.68$3.68MN/AN/A Is NPCE or ZJYL more profitable? Jin Medical International has a net margin of 0.00% compared to NeuroPace's net margin of -36.74%. Jin Medical International's return on equity of 0.00% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-36.74% -205.41% -28.29% Jin Medical International N/A N/A N/A SummaryNeuroPace beats Jin Medical International on 9 of the 15 factors compared between the two stocks. Remove Ads Get Jin Medical International News Delivered to You Automatically Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZJYL vs. The Competition Export to ExcelMetricJin Medical InternationalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$109.97M$8.83B$5.63B$7.83BDividend YieldN/A1.42%4.57%4.00%P/E RatioN/A17.2023.3318.67Price / Sales4.6865.69388.4691.01Price / Cash31.4419.6738.1634.64Price / Book3.905.416.894.23Net Income$3.68M$284.66M$3.20B$247.15M7 Day Performance6.76%-2.68%-2.98%-2.17%1 Month Performance2.17%-5.35%1.63%-5.68%1 Year Performance-81.71%-23.28%9.45%-0.74% Jin Medical International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZJYLJin Medical InternationalN/A$0.70-1.3%N/A-81.7%$109.97M$23.50M0.00245NPCENeuroPace3.0176 of 5 stars$12.30+2.3%$15.20+23.6%-10.2%$400.49M$79.91M-12.30170Short Interest ↑Positive NewsHigh Trading VolumeNYXHNyxoah2.7363 of 5 stars$11.30-0.5%$15.25+35.0%-43.3%$384.88M$4.52M-6.04110Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageCLPTClearPoint Neuro2.1718 of 5 stars$13.78+3.0%$25.00+81.4%+76.0%$380.77M$31.39M-19.97110Positive NewsSMLRSemler Scientific3.5661 of 5 stars$42.88+9.3%$71.00+65.6%+26.2%$376.38M$56.29M8.73120News CoveragePositive NewsNNOXNano-X Imaging1.7318 of 5 stars$6.12+1.2%$17.50+185.9%-46.5%$353.61M$10.68M-7.20190Options VolumeNews CoverageCVRXCVRx2.2923 of 5 stars$12.76+2.2%$17.83+39.8%-31.4%$332.22M$51.29M-4.74160Positive NewsSNWVSANUWAVE HealthN/A$38.71+2.9%N/AN/A$330.93M$29.30M-9.9340High Trading VolumeTCMDTactile Systems Technology3.312 of 5 stars$13.49+1.5%$18.00+33.4%-20.0%$318.16M$292.98M19.27980Positive NewsZIMVZimVie2.4325 of 5 stars$11.49-1.5%$23.00+100.2%-33.8%$318.01M$449.75M-0.882,700SMTISanara MedTech2.2877 of 5 stars$35.69+6.2%$47.00+31.7%-18.4%$311.97M$78.06M-36.0560Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies NPCE Competitors NYXH Competitors CLPT Competitors SMLR Competitors NNOX Competitors CVRX Competitors SNWV Competitors TCMD Competitors ZIMV Competitors SMTI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZJYL) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jin Medical International Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jin Medical International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
